Bio-Techne Corporation Announces Upcoming Investor Presentations
MINNEAPOLIS, Aug 26, 2024 /PRNewswire/ —
Bio-Techne Corporation (NASDAQ: TECH) has recently announced that Kim Kelderman, the President and Chief Executive Officer, will be presenting at several investor conferences in the upcoming weeks. This is exciting news for investors and those in the healthcare and life sciences industries.
Investor Conference Schedule:
Morgan Stanley 22nd Annual Global Healthcare Conference – September 4, 2024 at 4:05 PM EDT
Wells Fargo Healthcare Conference – September 6, 2024 at 11:00 AM EDT
Baird 2024 Global Healthcare Conference – September 10, 2024 at 1:25 PM EDT
For those who are unable to attend in person, a live webcast of the presentations will be available on Bio-Techne’s Investor Relations website.
Bio-Techne Corporation is a global life sciences company that focuses on providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Their presence at these investor conferences highlights their commitment to advancing technology and making a difference in the healthcare industry.
How This Announcement Will Affect Me:
As an investor, this announcement provides an opportunity to gain valuable insights into Bio-Techne Corporation’s current initiatives and future plans. By tuning in to the webcasts of these presentations, I can stay informed about the company’s performance and potential growth opportunities.
How This Announcement Will Affect the World:
Bio-Techne Corporation’s participation in these investor conferences not only showcases their products and services but also demonstrates their dedication to advancing healthcare and life sciences on a global scale. As a leading company in the industry, Bio-Techne’s presentations may inspire innovation and collaboration among other organizations, ultimately leading to advancements in research and clinical diagnostics worldwide.
Conclusion:
Overall, Bio-Techne Corporation’s upcoming investor presentations are a testament to their commitment to excellence and innovation in the healthcare and life sciences industries. By sharing their insights and initiatives with investors and the global community, Bio-Techne is paving the way for a brighter and healthier future for all.
